Vivani Medical, Inc. (VANI) Form 10-Q — May 13, 2026
Vivani Medical, Inc. is a clinical-stage biopharmaceutical company focusing on the development of miniature, ultra long-acting subdermal drug implant candidates. The company has no products approved for commercial sale and continues to incur significant operating losses. During the three months ended March 31, 2026, the company reported a net loss of $6.8 million, compared to $6.3 million in the same period of 2025.
Key figures
- Eps Beat
- 0
- Revenue
- 0
- Total Debt
- 0
- Debt Amount
- 0
- Revenue Yoy
- 0
- Total Assets
- 0
- Cash Position
- 19749
- Deal Value Usd
- 0
- Interest Rate
- 0
- Gross Proceeds
- 0
- Offering Price
- 0
- Shares Offered
- 0
- Shares Outstanding
- 84647803
- Net loss yoy
- 7.6
- Cash used in operating activities
- 6200
- Cash provided by financing activities
- 9700
Price after filing
1 day: +3.4%7 days: +2.6%30 days: -2.6%
Close on the filing date to close N calendar days later (from $1.16). Historical, not a forecast.
AI analysis
Red flags3 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.